Synergistic effect of sustained delivery of basic fibroblast growth factor and bone marrow mononuclear cell transplantation on angiogenesis in mouse ischemic limbs

This publication has 28 references indexed in Scilit:

• Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin
  Journal of Controlled Release, 2005
• Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium
  Biomaterials, 2005
• Smooth muscle-like tissues engineered with bone marrow stromal cells
  Biomaterials, 2004
• Combined transplantation of skeletal myoblasts and bone marrow stem cells for myocardial repair in rats
  European Journal of Cardio-Thoracic Surgery, 2004
• Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel
  Biomaterials, 2004
• Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial
  The Lancet, 2002
• Intrapericardial Delivery of Fibroblast Growth Factor-2 Induces Neovascularization in a Porcine Model of Chronic Myocardial Ischemia
  The Journal of Pharmacology and Experimental Therapeutics, 2000
• Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities
  Biomaterials, 1999
• Basic Fibroblast Growth Factor in a Porcine Model of Chronic Myocardial Ischemia: A Comparison of Angiographic, Echocardiographic and Coronary Flow Parameters
  The Journal of Pharmacology and Experimental Therapeutics, 1997
• Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation
  Cell, 1994